UnknownNCT05945342
Development and Application of Comprehensive Intervention Techniques for Adolescent Depression
Medication studyAges 12–18China
Understand this study
Who could participate?
Listed age limits: 12 years to 18 years.
- Listed locations
- HangzhouSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 31, 2023
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 100
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Locations
- China
- Age range
- From 12 Years to 18 Years
- Official registry ID
- NCT05945342
- Official title
Show the full official title
Research and Application of Key Technologies for Early Identification, Risk Warning and Comprehensive Intervention of Adolescent Depression
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hangzhou
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is First Affiliated Hospital of Zhejiang University, a university.
Does this study involve medication?
Yes. The study involves medication, including Escitalopram and Escitalopram combined with sham rTMS.
Who can participate?
Listed age limits: 12 years to 18 years.
